Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

about

Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.

P2860

Q37593480-80317798-7631-4B41-8967-CC29F6C2F9AD

P2860

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

Item

http://www.wikidata.org/entity/Q35738585

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@ast

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@en

type

Item

label

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@ast

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@en

prefLabel

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@ast

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@en

P1476

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

@en

P2093

Alvin L Smith

http://www.w3.org/2001/XMLSchema#string

Jason Paragas

http://www.w3.org/2001/XMLSchema#string

Joseph E Blaney

http://www.w3.org/2001/XMLSchema#string

Julie Dyall

http://www.w3.org/2001/XMLSchema#string

Lori E Dodd

http://www.w3.org/2001/XMLSchema#string

Reed F Johnson

http://www.w3.org/2001/XMLSchema#string

Sharon E Altmann

http://www.w3.org/2001/XMLSchema#string

P2860

An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge

Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.

Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.

Mechanism of action of mitoxantrone.

Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.

Cidofovir in the treatment of poxvirus infections.

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Obligatory requirement for antibody in recovery from a primary poxvirus infection

Evaluation of therapeutic interventions for vaccinia virus keratitis

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.

P304

305-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANTIVIRAL.2011.12.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter B. Jahrling

P577

2011-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51900925

http://www.w3.org/2001/XMLSchema#string

P698

22182595

http://www.w3.org/2001/XMLSchema#string

P932

3272698

http://www.w3.org/2001/XMLSchema#string

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

about

P2860

P2860

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932